Nkarta (NKTX) Research & Development (2019 - 2026)
Nkarta (NKTX) recorded Research & Development of $29.05 million in Q2 2026, up 39.8% from $20.78 million a year earlier and up 16.2% from the prior quarter.
Powered by 
Analysis
Nkarta (NKTX) Research & Development (2019 - 2026) Analysis & Trends
On a TTM basis, Nkarta's Research & Development came in at $99.51 million as of Jun 30, 2026, up 6.6% year-over-year; for FY2025, it was $90.43 million, down 6.5% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 20.1% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $96.74 million in FY2024 (unchanged), $96.77 million in FY2023 (+6.5%), $90.9 million in FY2022 (+43.3%) and $63.41 million in FY2021 (+75.1%).
- The Q2 2026 figure is the highest quarterly Research & Development in data going back to Q2 2019.
- On a year-over-year basis, Research & Development has increased for three consecutive quarters, with growth averaging 3.9% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 69.1% in Q3 2021, against a decline of 20.0% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $24.99 million (Q1 2026), $25.28 million (Q4 2025) and $20.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Nkarta | 191.24 Mn | 191.24 Mn | - | 29.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.05 Mn |
| Mar 31, 2026 | 24.99 Mn |
| Dec 31, 2025 | 25.28 Mn |
| Sep 30, 2025 | 20.20 Mn |
| Jun 30, 2025 | 20.78 Mn |
| Mar 31, 2025 | 24.17 Mn |
| Dec 31, 2024 | 23.13 Mn |
| Sep 30, 2024 | 25.25 Mn |
| Jun 30, 2024 | 23.13 Mn |
| Mar 31, 2024 | 25.24 Mn |
| Dec 31, 2023 | 23.32 Mn |
| Sep 30, 2023 | 22.19 Mn |
| Jun 30, 2023 | 25.12 Mn |
| Mar 31, 2023 | 26.14 Mn |
| Dec 31, 2022 | 26.84 Mn |
| Sep 30, 2022 | 23.44 Mn |
| Jun 30, 2022 | 21.05 Mn |
| Mar 31, 2022 | 19.57 Mn |
| Dec 31, 2021 | 17.30 Mn |
| Sep 30, 2021 | 16.62 Mn |
API Access
Nkarta Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();